CASSANDRA MEMERING: Open Payments
NPI 1538663331 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 29 payments from 10 companies in 2025. Trend: 2023 $522 · 2024 $729 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $204 |
| Sumitomo Pharma America, Inc. | 5 | $103 |
| PFIZER INC. | 4 | $76 |
| Astellas Pharma US Inc | 3 | $60 |
| TOLMAR, INC. | 3 | $49 |
| Calyxo, Inc. | 1 | $23 |
| IMMUNITYBIO, INC. | 1 | $21 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $15 |
| Laborie Medical Technologies Corp. | 1 | $11 |
Products named: XTANDI, ERLEADA, RYBREVANT, GEMTESA, ORGOVYX, JATENZO, CVAC ASPIRATION SYSTEM, ANKTIVA.
Industry payments across IN — which companies pay providers there.
